CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous recombination of AAV donor vectors
摘要:
The present invention relates to a system and method for efficiently modifying the genome of cells to treat diseases via sequential homologous recombination using CRISPR/Cas-mediated genome editing with donor DNA delivered by two or more adeno-associated virus (AAV) vectors.
信息查询
0/0